1st Quarter - Report — EAST END GROUP, LLC for ALVOGEN (2026)

Firm

EAST END GROUP, LLC

Client

ALVOGEN

Income

$45,000

Expenses

—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Funding for pandemic influenza antivirals in the LHHS Appropriations bill. Regulatory and legislative issues related to development and procurement of pandemic influenza antivirals. Issues related to domestic manufacturing and on-shoring pharmaceuticals.

Foreign entity interest: Alvogen Luxembourg SARL; Temasek Singapore

Lobbyist	Covered position, as disclosed
KELLY CHILDRESS LANGE	Rep. Shimkus, LA; Rep. Rogers, Health Policy Adviser.

Contacted: SENATE; HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); White House Office

Tariff (miscellaneous tariff bills) TAR

Section 232 investigation into pharmaceuticals and unfair trade practices.

Foreign entity interest: Alvogen Luxembourg SARL; Temasek Singapore

Lobbyist	Covered position, as disclosed
KELLY CHILDRESS LANGE	Rep. Shimkus, LA; Rep. Rogers, Health Policy Advisor

Contacted: U.S. Trade Representative (USTR); White House Office; Commerce, Dept of (DOC)

Manufacturing MAN

Buy America legislation, 232 tariff investigation, regulatory incentives for domestic manufacturing.

Foreign entity interest: Alvogen Luxembourg SARL; Temasek Singapore

Lobbyist	Covered position, as disclosed
KELLY CHILDRESS LANGE	Rep. Shimkus, LA; Rep. Rogers, Health Policy Advisor

Contacted: White House Office; HOUSE OF REPRESENTATIVES; SENATE; Health & Human Services, Dept of (HHS)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.